Welcome to our dedicated page for IB Acquisition SEC filings (Ticker: IBAC), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
IB Acquisition Corp. filings document the formal disclosure record of a SPAC, including trust-account amendments, deadline-extension mechanics, shareholder votes, material definitive agreements and capital-structure terms. The company’s reports describe common stock and rights listed on Nasdaq, with each right entitling the holder to receive one-twentieth of one share upon consummation of an initial business combination.
Its SEC record includes Form 8-K material-event reports and proxy materials covering special-meeting proposals, amendments to the Investment Management Trust Agreement, articles-of-incorporation changes, redemption and liquidation provisions, governance matters and business-combination related agreements.
IB Acquisition Corp. (IBAC) is asking stockholders to approve several changes that would give the company more time to complete its initial business combination and avoid an automatic wind‑up. The main proposal extends the business‑combination deadline by six months, from September 28, 2026 to March 28, 2027, by amending the charter; this requires approval by holders of at least 65% of outstanding common shares, including Founder Shares.
A second proposal amends the Investment Management Trust Agreement so the Trust Account terms match the new deadline, and a third allows adjournment of the meeting if more time is needed to solicit votes. Public stockholders may redeem their shares in connection with the extension for cash equal to their pro rata share of the Trust Account, which held approximately $8.3 million as of the record date, implying an expected redemption price of about $10.93 per share. If the extension is not approved and no business combination closes by September 28, 2026, IB Acquisition must redeem 100% of public shares from the Trust Account and then dissolve, leaving only liquidation value and no future upside from any potential transaction.
IB Acquisition Corp. (IBAC) is calling a virtual special meeting on September 24, 2026 to ask stockholders to approve three proposals focused on extending its timeframe to complete an initial business combination and aligning its trust terms with that extension.
Proposal 1 (Extension Proposal) would amend the charter to extend the deadline to complete a business combination by six months, from September 28, 2026 to March 28, 2027, at the company’s election. Approval requires the affirmative vote of 65% of all outstanding common shares, including founder shares. Public stockholders will have the right to redeem their public shares for cash in connection with the extension and again in connection with any later business combination vote or a future liquidation. The company must maintain at least $5,000,001 of net tangible assets after redemptions to proceed with the extension.
Proposal 2 (Trust Amendment Proposal) would amend the Investment Management Trust Agreement so the trust can operate consistently with the extended deadline. It requires approval by a majority of outstanding common shares. Proposal 3 would allow adjournment of the meeting if there are insufficient votes for Proposals 1 or 2. As of the record date, there were 5,008,229 shares outstanding and insiders and related parties held 3,613,590 shares (about 63.0%). If the extension is not approved and no business combination closes by September 28, 2026, IBAC states it will redeem 100% of public shares from the trust and liquidate.
IB Acquisition Corp., a SPAC, reported a net loss of $567,166 for the quarter and $1,265,934 for the nine months ended June 30, 2026, compared with income in the prior-year periods. General and administrative expenses rose sharply while interest income from the Trust Account declined.
Cash and investments in the Trust Account were $8,261,479 and cash outside the trust was only $30,161, with a working capital deficit of $2,190,878. Management disclosed substantial doubt about the company’s ability to continue as a going concern.
The company has entered into a Business Combination Agreement with GNQ Insilico Inc., supported by shareholder and sponsor agreements and a bridge financing structure of up to $2,000,000, including an initial $250,000 10% secured convertible note and accompanying warrants. Large stockholder redemptions removed approximately $106.1 million and $7.9 million from the Trust Account in two extension votes, leaving 759,139 public shares subject to redemption.
IB Acquisition Corp. reported a net loss of $639,866 for the quarter ended March 31, 2026, driven by higher general and administrative expenses of $748,177 and reduced interest income from its trust investments.
The SPAC’s trust account balance fell to $8.19M after significant redemptions, including about $7.9M at roughly $10.78 per share in March 2026. Common stock subject to possible redemption declined to 759,139 shares, while 4,249,090 non‑redeemable shares remained outstanding.
IB Acquisition entered into a Business Combination Agreement with GNQ Insilico Inc. and arranged up to $2.0M of 10% secured convertible bridge financing to support GNQ ahead of closing. Management disclosed only $4,634 of cash outside the trust and a working capital deficit of $1.55M, concluding these conditions raise substantial doubt about the company’s ability to continue as a going concern absent a successful merger.
IB Acquisition Corp. filed an 8-K reporting that GNQ Insilico, Inc. entered a global Joint Initiative Marketing Agreement with IBM, signed in March 2026, to accelerate adoption of personalized, data-driven medicine. The press release is attached as Exhibit 99.1.
This report also states that the filing relates to a proposed business combination between IBAC and GNQ. IBAC intends to file a registration statement on Form S-4 that will include a proxy statement/prospectus to be sent to IBAC stockholders. The 8-K cautions that the transaction remains subject to customary closing conditions and regulatory approvals.
IB Acquisition Corp. schedule amendment shows AQR Capital Management, LLC, AQR Capital Management Holdings, LLC and AQR Arbitrage, LLC report 0 shares beneficially owned of common stock, representing 0% of the class as of 03/31/2026. The filing lists issuer address and identifies parent/subsidiary relationships; it is signed and dated 04/08/2026.
IB Acquisition Corp. obtained stockholder approval to extend the deadline to complete its initial business combination from March 28, 2026 to September 28, 2026 through amendments to its trust agreement and articles of incorporation. If no deal is completed by September 28, 2026, the trust account will be liquidated under specified redemption and liquidation procedures, with no trust amounts used to pay dissolution expenses. The changes also clarify that trust funds generally remain locked except for interest used to pay franchise and income taxes, and reinforce public stockholders’ rights to redeem their shares in connection with key charter amendments affecting redemptions or the business combination timeline.
IB Acquisition Corp. reported the results of a special stockholder meeting and related redemptions of its common stock. Stockholders owning 5,077,821 shares, or about 88.46% of shares outstanding as of the February 11, 2026 record date, were present or represented by proxy.
Each proposal voted on at the meeting received 5,007,821 votes for and 70,000 against, with no abstentions or broker non-votes, so all proposals were approved. Separately, holders of 731,741 shares chose to redeem their shares for cash at approximately $10.78 per share from the company’s trust account.
These redemptions will remove about $7.9 million from the trust account, leaving approximately $8.2 million remaining. The remaining trust balance may change to reflect tax withdrawals.
AQR-affiliated investment funds reported open-market sales of IB Acquisition Corp. common stock. On March 23, 2026, entities managed by AQR Capital Management sold a combined 335,000 shares of common stock at $10.80 per share.
The transactions were executed across multiple vehicles, including AQR Global Alternative Investment Offshore Fund, L.P., which held 143,785 shares after its sale, and other funds such as AQR Diversified Arbitrage Fund and several AQR arbitrage and UCITS funds. The sales are reported by AQR Capital Management Holdings, LLC, AQR Capital Management, LLC, and AQR Arbitrage LLC as indirect holdings of ten percent owners.
AQR-related investment entities reported an open-market sale of IB Acquisition Corp. common stock. An account identified as AQR DELTA Master Account, L.P. sold 4,619 shares of common stock on 2026-03-20 at $10.75 per share in an indirect transaction. After this sale, that indirect account held 0 shares of IB Acquisition Corp.